1. Food and Drug Administration. Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff [Internet]. Silver Spring (MD): Food and Drug Administration;2023. updated 2023 October 19. cited 2024 February 9. Available from:
https://www.fda.gov/media/136290/download.
3. Kwon S, Choi EK, Lee SR, et al. Comparison of novel telemonitoring system using the single-lead electrocardiogram patch with conventional telemetry system. Korean Circ J. 2024; 54:140–153. PMID:
38506104.
4. Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022; 24:979–1005. PMID:
35368065.
5. Mittal S, Piccini JP, Snell J, Prillinger JB, Dalal N, Varma N. Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. J Interv Card Electrophysiol. 2016; 46:129–136. PMID:
26860839.
6. Spatz ES, Ginsburg GS, Rumsfeld JS, Turakhia MP. Wearable digital health technologies for monitoring in cardiovascular medicine. N Engl J Med. 2024; 390:346–356. PMID:
38265646.
7. Nakayama A, Ishii N, Mantani M, et al. Remote cardiac rehabilitation with wearable devices. Korean Circ J. 2023; 53:727–743. PMID:
37973385.
8. Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ Digit Med. 2022; 5:121. PMID:
35986056.
9. Ju JH, Sim B, Lee J, Lee JY. Reimbursement of digital therapeutics: future perspectives in Korea. Korean Circ J. 2022; 52:265–279. PMID:
35388995.
10. Mittermaier M, Venkatesh KP, Kvedar JC. Digital health technology in clinical trials. NPJ Digit Med. 2023; 6:88. PMID:
37202443.